Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Alnylam Pharmaceuticals, Inc. ALNY

Set alert

Price alert · ALNY

All alert types
158.00 USD -7.00 -4.24%

At close · Nov 2

159.06 +1.06 +0.67%

After hours · Nov 2, 6:19 PM ET

Bid
157.88 × 1
Ask
157.99 × 2
156.00 Day range 163.90
156.00 52-week range 479.79
YTD
-60.27%
1 year
-65.35%
Open
163.10
Prev close
165.00
Mkt cap
21.16B
Vol
4.76M
Avg vol
1.83M
EPS
19.80
P/E
7.98
Div yield
0.00%
More statistics
Low
156.00
High
163.90
Forward P/E
14.17
Beta
0.44
Short ratio
5.02
Inst. own
101.57%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2027
50-d avg
236.49
200-d avg
285.48
1y target
305.70

5D chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 29, 2026Earnings: 16.26; estimate 1.66; surprise 879.52%
  • Oct 30, 2026Downgrade: Bernstein · Outperform → Market Perform
  • Oct 30, 2026Rating: TD Cowen · Buy → Buy
  • Oct 30, 2026Rating: UBS · Buy → Buy
  • Nov 2, 2026Rating: Canaccord Genuity · Buy → Buy
  • Nov 2, 2026Downgrade: Truist Securities · Buy → Hold
  • Nov 2, 2026Rating: Barclays · Overweight → Overweight
Signals (144)
NameTimeAgo
RSI: OversoldNov 2, 3:55 PM7 hours ago
SMA: BearishNov 2, 3:25 PM8 hours ago
SMA: BearishNov 2, 3:25 PM8 hours ago
SMA: BullishNov 2, 3:05 PM8 hours ago
SMA: BullishNov 2, 3:05 PM8 hours ago
SMA: BearishNov 2, 2:40 PM8 hours ago
MACD: Sell SignalNov 2, 2:40 PM8 hours ago
SMA: BearishNov 2, 2:35 PM8 hours ago
SMA: BullishNov 2, 1:45 PM9 hours ago
SMA: BullishNov 2, 1:45 PM9 hours ago
MACD: Buy SignalNov 2, 1:45 PM9 hours ago
SMA: BearishNov 2, 1:40 PM9 hours ago
SMA: BearishNov 2, 1:40 PM9 hours ago
SMA: BullishNov 2, 1:35 PM9 hours ago
SMA: BullishNov 2, 1:35 PM9 hours ago
SMA: BearishNov 2, 1:10 PM10 hours ago
MACD: Sell SignalNov 2, 1:10 PM10 hours ago
SMA: BearishNov 2, 1:05 PM10 hours ago
SMA: BullishNov 2, 12:40 PM10 hours ago
SMA: BearishNov 2, 12:30 PM11 hours ago

Newest 20 of 144.

Revenue & Expenses

Revenue by
Amvuttra → Revenue: $2.31BRevenue → Gross Profit: $3.04BGross Profit → Net Income: $313.75MGross Profit → Selling, General & Admin: $1.21BGross Profit → Research & Development: $1.32BRevenue → Cost of Revenue: $677.17MGross Profit → Other Expenses: $178.43MGross Profit → Income Tax: $9.40MNet revenues from collaborations → Revenue: $553.37MGivlaari → Revenue: $308.49MOxlumo → Revenue: $191.44MRoyalty revenue → Revenue: $174.02MOnpattro → Revenue: $172.79MGross Profit$3.04BCost of Revenue$677.17MNet Income$313.75MSelling, General & Admin$1.21BResearch & Development$1.32BOther Expenses$178.43MIncome Tax$9.40MRevenue$3.71BAmvuttra$2.31BNet revenues from collaborations$553.37MGivlaari$308.49MOxlumo$191.44MRoyalty revenue$174.02MOnpattro$172.79M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
ALNY annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.71B2.25B1.83B1.04B844.29M
3.03B1.92B1.52B868.60M704.14M
501.58M-176.88M-282.18M-785.07M-708.65M
313.75M-278.16M-440.24M-1.13B-852.82M
2.33-2.18-3.52-9.30-7.20

Balance sheet

Full balance sheet How to read it
ALNY annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.66B966.43M812.69M866.39M819.98M
4.97B4.24B3.83B3.55B3.64B
4.18B4.17B4.05B3.70B3.06B
2.97B3.14B2.68B2.61B2.19B
789.18M67.09M-220.64M-158.22M588.20M

Cash flow

Full cash flow How to read it
ALNY annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
524.08M-8.31M104.16M-541.27M-641.69M
436.33M-116.84M-336.35M169.35M-273.30M
-305.19M294.16M172.13M425.75M1.25B
-58.70M-34.28M-62.21M-72.06M-76.37M
690.15M153.77M-53.67M46.40M323.11M